© PHARMED CANADA

Programme 2016 

Prenez note que la conférence aura lieu essentiellement en anglais

​7:45-8:30

Inscription 

​8:30 - 8:45

Mots d'ouverture


Perry Niro, President, Pharmed Canada 

 

8:45 - 9:30

Global life sciences sector outlook

2016 Deals, M&A and partnering forecast for 2017

 

  • Douglas Loe, Analyst, Healthcare & Biotech, Echelon Wealth Partners

​9:30-10:15

Partnering across the borders with Pharma Ventures

  ​

  • Jennifer Hamilton, Senior Director, New Ventures (Canada), Johnson & Johnson Innovation
  • Steven Xanthoudakis, Director, Business Development & Licensing at Merck
  • Amyn Sayani, Ph.D., Director, R&D Alliances, GlaxoSmithKline Canada

​10:15 - 10:35

Pause

​10:35 - 11:30

Cross-border VC Deals: Joining the Dots

Modéré par Stephen Nagler, Executive Director, MedPro Investors,  New York

  • Alex Zisson, Managing Director, HIG Capital, New York

  • Caroline Stout, Investor, EcoR1 Capital,  San Francisco

  • Josh Richardson, Principal, Longitude Capital, Menlo Park, California

​11:30 - 12:15

CEO Panel: Show me the money, dealing with VCs!

Modéré par  Didier Leconte, Senior Director, Investments - Life Sciences, FSFTQ​
 

  • Panel of 3 CEO who accomplished major fundraising this year !

Midi Conférence
Conférencier à confirmer

​13:45 - 14:30

Life Sciences EY Report 2016

Beyond borders,  Reaching new heights

  • Sylvain Boucher, CPA, Partner, EY Canada

​14:30 - 15:15

How to commercialize Digital Health and Medical Technologies

Modéré par  Jean-Francois Pariseau, Partner, Healthcare Fund, BDC Venture Capital
  • Ajit Singh, Partner, Artiman Ventures , Palo Alto

  • Brent Norton,  Venture Partner, Lumira Capital, Toronto

​15:15 - 15:30

Pause

​15:45 - 16:45

Healthcare: Opportunities & Challenges for Medtech

Modéré par  Yvan Beaudoin,  Executive Director, CTS Santé Fund

Panel of entrepreneurs and investors

 

16:45

Conclusions et Cocktail​